Lifeward (LFWD) to Post Quarterly Earnings on Friday

Lifeward (NASDAQ:LFWD) is anticipated to post its Q2 2026 results before the market opens on Friday, August 14th. Analysts expect the company to post earnings of ($1.3862) per share and revenue of $6.5310 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, August 14, 2026 at 9:30 AM ET.

Lifeward (NASDAQ:LFWD) last posted its earnings results on Friday, May 15th. The company reported ($6.70) EPS for the quarter, missing the consensus estimate of ($1.18) by ($5.52). Lifeward had a negative return on equity of 243.14% and a negative net margin of 123.66%.The firm had revenue of $3.92 million during the quarter, compared to the consensus estimate of $5.78 million. On average, analysts expect Lifeward to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Lifeward Stock Performance

Shares of LFWD stock opened at $7.75 on Thursday. The firm has a market capitalization of $21.93 million, a price-to-earnings ratio of -0.39 and a beta of 0.38. The business has a 50 day simple moving average of $7.41 and a 200 day simple moving average of $6.99. Lifeward has a 12-month low of $4.14 and a 12-month high of $10.56. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.40 and a quick ratio of 1.82.

Institutional Investors Weigh In On Lifeward

Institutional investors have recently modified their holdings of the stock. HRT Financial LP grew its holdings in shares of Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after acquiring an additional 29,423 shares in the last quarter. Virtu Financial LLC raised its holdings in shares of Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares in the last quarter. Jane Street Group LLC boosted its position in Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after purchasing an additional 29,927 shares during the last quarter. Finally, Citadel Advisors LLC boosted its position in Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the last quarter. Institutional investors and hedge funds own 26.76% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on LFWD. Zacks Research raised shares of Lifeward from a “strong sell” rating to a “hold” rating in a research note on Monday, July 27th. Weiss Ratings upgraded shares of Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $10.00.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.